Syracuse, New York • Velocity Clinical Research
Phone: (315) 760-5905
Hypertriglyceridemia refers to an elevated level of triglycerides (TG) or lipids in the bloodstream. A severe elevation of triglycerides can increase a person's risk for pancreatitis. Elevations of TG may also lead to an increased risk of atherosclerotic cardiovascular (CV) events even when the LDL-C is well controlled by statin therapy.
Velocity is conducting a clinical research study for an investigational medication for severe hypertriglyceridemia.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy